Multiple genes are likely to be involved in obesity and these genes may interact with environmental factors to influence obesity risk. Our aim was to explore the synergistic contribution of the two polymorphisms: Pro12Ala of the PPARg2 gene and Trp64Arg of the ADRb3 gene to obesity risk in a Spanish children and adolescent population. METHODS: We designed a sex-and age-matched case-control study. Participants were 185 obese and 185 control children (aged 5-18 y) from the Navarra region, recruited through Departments of Pediatrics (Hospital Virgen del Camino, Navarra University Clinic and several Primary Health Centers). The obesity criterion (case definition) was BMI above the 97th percentile according to Spanish BMI reference data for age and gender. Anthropometric parameters were measured by standard protocols. The genotype was assessed by PCR-RFLP after digestion with BstUI for PPARg2 mutation and BstNI for ADRb3 variants. Face-toface interviews were conducted to assess the physical activity. Using a validated physical activity questionnaire, we computed an activity metabolic equivalent index (METs h/week), which represents the physical exercise during the week for each participant. Statistical analysis was performed by conditional logistic regression, taking into account the matching between cases and controls. RESULTS: Carriers of the polymorphism Pro12Ala of the PPARg2 gene had a significantly higher obesity risk than noncarriers (odds ratio (OR) ¼ 2.18, 95% CI ¼ 1.09-4.36) when we adjusted for sex, age and physical activity. Moreover, the risk of obesity was higher (OR ¼ 2.59, 95% CI ¼ 1.17-5.34) when family history of obesity was also taken into account in the model. The OR for obesity linked to both polymorphisms (PPARg2 and ADRb3) was 5.30 (95% CI ¼ 1.08-25.97) when we adjusted for sex, age and physical activity. After adjustment for family history of obesity, the OR for carriers of both polymorphisms was 19.5 (95% CI ¼ 2.43-146.8). CONCLUSIONS: A synergistic effect between polymorphism Pro12Ala of the PPARg2 gene and Trp64Arg of the ADRb3 gene for obesity risk was found in a case-control study including children and adolescents.
Introduction
Multiple genes, likely to be involved in obesity, may interact with environmental provocations to influence obesity risk. 1, 2 The search for gene Â gene interactions is the subject of growing interest since the combined risk conferred by multiple gene variants will be greater than that expected from a simple addition of each risk factor. Two polymorphisms whose respective gene products influence fat accumulation were studied: Trp64Arg of beta-3-adrenergic receptor (ADRb3) and Pro12Ala of peroxisome proliferator-activatedreceptor gamma 2 (PPARg2). Both are reported to be implicated in the etiology of obesity, although negative findings are also found in some studies. 3, 4 Their allelic frequencies range from 0.08 to 0.25 for the polymorphism Pro12Ala of the PPARg2 gene and from 0.05 to 0.19 for Trp64Arg variant of the ADRb3 gene in Caucasian populations. [5] [6] [7] [8] [9] [10] Interestingly, Hsueh et al 11 found a gene Â gene interaction on obesity between variants of ADRb3 (Trp64Arg) and PPARg2 (Pro12Ala) in Mexican-American adults. They reported that these two polymorphisms accounted for 2-3% of the total variation in BMI, serum insulin and leptin, with the interaction accounting for about half of their total effect. Here, we aimed to explore the synergistic contribution of these two polymorphisms (Pro12Ala PPARg2 and Trp64Arg ADRb3) to obesity risk in Spanish children and adolescent population through a sexand age-matched case-control study.
Methods

Study population
The study population, recruited from the Pediatric Departments at the Virgen del Camino Hospital, Navarra University Hospital and three Primary Health Centers, comprised 370 Spanish children and adolescents (185 obese and 185 control subjects), aged 5-18 y. We based the study on a case-control design. Obesity was defined according to Spanish BMI reference data, since our main interest was to estimate the obesity risk for Spanish children and adolescents. Therefore, cases were subjects with BMI above the 97th percentile of the Spanish BMI reference data for age and gender, while controls were subjects with a BMI below the 97th percentile. Most of the cases and control subjects (98.4%) were Caucasians originating from a homogenous population in a limited geographical area in the North of Spain, except for a small proportion of subjects (1.6%) who were non-Caucasian (three subjects from South America, one Hindu, one AfroAmerican and one Gypsy subject). Controls were matched to the obese subjects with regard to sex and age on a 1 : 1 basis (76 months). The exclusion criteria were exposure to hormonal treatment or development of secondary obesity due to endocrine disorder or serious intercurrent illness. Controls were healthy subjects having a BMI for age below the 97th percentile with no hormonal treatment or endocrinological disease, assisted at the same hospitals or health centers as the cases. The study was approved by the Ethics Committee of the University of Navarra and all parents and subjects above 12 y provided written informed consent. Children below 12 y assented to participate in the study. The reported investigation has been carried out according to the principles of the Declaration of Helsinki II.
Procedures
Anthropometric measurements were made by standard procedures and fat mass was measured by bioelectrical impedance (TBF-410, TANITA r , Tokio, Japó n). Blood samples were taken for the extraction of genomic DNA from leukocytes. The two polymorphisms were analyzed by PCR-RFLP. 12, 13 The DNA segment containing codon 12 of the 0 . The PCR product (210 bp) was incubated with BstNI and digested samples were separated by electrophoresis through a 2.5% agarose gel.
Trained researchers conducted face-to-face interviews with participants and their parents in a pre-established way. A previously validated physical activity questionnaire was used; 14, 15 it included 17 activities and sports and nine options of response categories with frequencies ranging from 'never/almost never' to 'six or more times per day'. We assigned a multiple of resting metabolic rate (MET score) to each activity. With this information, we computed an activity metabolic equivalent index (METs h/week), which represents the physical exercise during the week for each participant. The interview included questions about family relatives suffering from obesity, diabetes (types 1 and 2), dyslipidemia and thyroid disease. Four participants of the study were adopted children, so their family history data were unavailable.
Statistical analysis
Descriptive values are given as the means and standard errors of the means. Univariate statistical analysis was performed using unpaired Student's t-test, Fisher's test and w 2 test. For non-normally distributed data, the Mann-Whitney U-test was used. Multivariate conditional logistic regression was used to estimate odds ratios (ORs) and adjust for potential confounding factors. Two models of conditional logistic regression were used to establish the risk of obesity associated with every polymorphism. In the first model, ORs were adjusted by physical activity (categorized in quintiles) and also for age and sex, since these were the matching variables, and we used conditional logistic regression. In the second model, family history of obesity was also included as a dichotomous variable (one for subjects having father, mother or siblings with obesity and zero for subjects without any obese first-degree relative). Dummy variables were introduced in the second model to establish the risk of obesity associated with having one, another or both polymorphisms, using the absence of both polymorphisms as the reference category.
Results Table 1 shows the main clinical characteristics of the participants (n ¼ 370). The mean age was 11 y and the proportion of males was 53%. As expected, cases significantly differed from controls with regard to BMI, body fat mass and several other characteristics linked to obesity.
PPARc2 and ADRb3 and obesity risk in children MC Ochoa et al
Physical activity was significantly lower in cases vs controls (Po0.001, Table 1 ), but quite similar between carriers and non-carriers of each polymorphism (data not shown). Subject distribution categorized by genotype is presented in Table 2 . The prevalence of the Pro12Ala polymorphism of the PPARg2 gene was slightly higher in cases (2% homozygotes for the Ala allele, 22% heterozygotes Ala/Pro and 76 % homozygotes for the Pro allele) compared to controls (17% heterozygotes Ala/Pro and 83% homozygotes for the Pro allele), but differences were not statistically significant (P ¼ 0.112, two-tailed Fisher test). For the Trp64Arg polymorphism, the crude prevalence was more similar in cases (13% heterozygotes Trp/Ala and 87% homozygotes for the Trp allele) than in controls (16% heterozygotes Trp/Ala and 84% homozygotes for the Trp allele) (P ¼ 0.458, w 2 test).
Moreover, the frequency values for the two polymorphisms were 5% in cases and 3% in controls. All the polymorphism frequencies did not deviate from the Hardy-Weinberg prediction (P40.10). Tables 3 and 4 show the relative risks for obesity linked to PPARg2 and ADRb3 variants following two statistical approaches. We controlled for physical activity in quintiles (METs h/week) and family history of obesity. Interestingly, carriers of the polymorphism Pro12Ala of the PPARg2 gene had a significantly higher obesity risk than non-carriers (OR ¼ 2.18, 95% CI ¼ 1.09-4.36; P ¼ 0.027) when adjustment for sex, age and physical activity (model 1, Table 3 ) was carried out. Moreover, the risk of obesity was higher (OR ¼ 2.59, 95% CI ¼ 1.17-5.34; P ¼ 0.002) when family history of obesity was also taken into account in the analysis (model 2). The Trp64Arg polymorphism of the ADRb3 gene itself did not influence obesity risk in our population (Table 4) . Table 5 shows the joint effect of PPARg2 and ADRb3 gene variants on obesity risk. The most interesting data were that the ORs for obesity linked to the two polymorphisms rose up to 5.30 (95% CI ¼ 1.08-25.97; P ¼ 0.039) when we adjusted for sex, age and physical activity and even to 19.5 (95% CI ¼ 2.43-156.8; P ¼ 0.005) after additional adjustment for family history of obesity. When we introduced a productterm (gene Â gene) in the fully adjusted model, the P-value for the likelihood ratio test was P ¼ 0.039. Graphically, the higher mean BMI values of children and adolescents carrying the two polymorphisms are shown in Figure 1 .
Discussion
The purpose of the present study was to examine the effect of two different polymorphisms: Pro12Ala of the PPARg2 gene and Trp64Arg of the ADRb3 gene on obesity risk in children and adolescents. The most interesting finding was a significant gene Â gene interaction between the two gene variants. Indeed, subjects carrying the two polymorphisms of the PPARg2 and ADRb3 genes have an adjusted OR of 19.5 for obesity risk. We also found a significant higher obesity risk for children carriers of the Pro12Ala variant of the PPARg2 gene. In the literature, several studies reported the existence of a positive interaction for weight gain between ADRb3 and UCP1 gene variants. [16] [17] [18] But there is only one previous report concerning ADRb3 and PPARg2 gene variants interactions. In a cross-sectional study, Hsueh et al 11 found a gene Â gene interaction between polymorphisms Pro12Ala of the PPARg2 gene and Trp64Arg of the ADRb3 gene. They reported that subjects with these two gene variants had significantly higher BMI, serum leptin and insulin levels than those with only the PPARg2 variant. There is little information on interactions of PPARg2 gene with other genes. In a meta-analysis examining the Pro12Ala polymorphism in 19 136 subjects, a positive association with BMI was found. 19 In our study, the frequency of the Ala allele was similar to other Caucasian populations [5] [6] [7] [8] and was higher in obese subjects (allelic frequency 0.13) than in controls (0.08), suggesting that this polymorphism was associated with obesity. Further confirmation of this effect was obtained using conditional logistic regression to adjust for confounding.
Matched case-control studies offer the possibility of calculating OR for a disease risk, with an efficient control for the confounding effect of the matching factors. In regard to lifestyle influences, it is well known that physical activity has an inverse relationship to obesity; to avoid bias in the estimation of obesity risk, we have adjusted for quintiles of physical activity (METs h/week). 20 Another confounding factor that allows us to adjust for lifestyle influences and also for genetic factorsFnot under the scope of this workFis family history of obesity. In the literature, there are many case-control studies that estimate risk of disease associated to a particular gene variant after adjustment for family history of disease. 21, 22 However, as this could cause a overadjustment, we have calculated two different ORs taking family history of obesity into account or not. In our study, OR for obesity associated to ADRb3 and PPARg2 gene variants is higher in model two (after adjustment for family history of obesity) than in model one. This could be explained because the familiar predisposition represents a much stronger genetic load than the presence of single polymorphisms. There is some evidence for the functionality of these two variants. In vitro analysis and cold exposure indicated that ADRb3 activation enhanced PPARg2 expression levels. The two mutant proteins appear to have a reduced activity, but little is known about how these two proteins interact with each other. 23 Additional functional and genetic studies are required to confirm the synergetic effect of these two loci on the risk of obesity. In summary, we have found a synergistic effect between Pro12Ala of the PPARg2 and Trp64Arg of the ADRb3 gene variants in our Spanish children and adolescent population.
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